FlandersBio on Twitter

Ablynx announces Q1 2012 Business Update: http://t.co/FGa476Yu

Follow us on Twitter

Archive for 2012 - Events

Archive for 2012 - Evenementen

in het nederlands in english

FlandersBio organises events that provide opportunities for networking and tapping into the knowledge and expertise of all the life sciences companies. We also keep you informed about other interesting life sciences events. You can also send us your life sciences event.

FlandersBio organiseert seminaries en workshops om het netwerken te bevorderen. Op die manier delen bedrijven gespecialiseerd in biowetenschappen ook hun knowhow en expertise met elkaar. Verder houden we u ook op de hoogte van andere interessante evenementen die gelinkt zijn met de biowetenschappen. Stuur gerust ons gerust jouw evenement door.

Webinar: Pharmacological Characterization of BI 847325, a Dual Inhibitor of MEK and Aurora Kinases

17.05.2012

Join us for this informative webinar on how the OncoPanel is utilized in characterizing a BI 847325, a Dual Inhibitor of MEK and Aurora Kinases. read more

Immunotherapy Leaders' Forum 2012

09.05.2012 - 11.05.2012

Phacilitate’s Active Immunotherapy Forum is now in its 5th year, and for 2012 we are broadening the scope of the meeting to encompass more of the exciting new immunotherapy modalities under development today, creating the Immunotherapy Leaders’ Forum. read more

I-SUP 2012 - Innovation for Sustainable Production

06.05.2012 - 09.05.2012

i-SUP2012 expects your expertise on Cleantech to transform our planet Earth in a sustainable way. read more

The World Congress on Industrial Biotechnology and Bioprocessing

29.04.2012 - 02.05.2012

The World Congress on Industrial Biotechnology and Bioprocessing is the world's largest industrial biotechnology event for business leaders, investors and policy makers in biofuels, biobased products, and renewable chemicals. read more

Open Innovation in Pharmaceutical R&D

26.04.2012 - 27.04.2012

As we are experiencing a lag between R&D spending and the extraction of value from that investment, open innovation presents an opportunity to break the mould of current drug research, innovate exponentially without expanding R&D investment and speed the development of tomorrow’s lifesaving medicines for diseases. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Past events

Back to top

Print